Use of Natalizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis in Kuwait

Publisher： Karger

E-ISSN： 1423-0151|22|5|495-499

ISSN： 1011-7571

Source： Medical Principles and Practice, Vol.22, Iss.5, 2013-06, pp. : 495-499

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effectiveness of Natalizumab in Patients with Highly Active Relapsing Remitting Multiple Sclerosis

By  

European Neurology, Vol. 73, Iss. 3-4, 2015-0 ,pp. : 220-229

Karger

Access to resources Recommend Favorite

Escalating Immunotherapy with Mitoxantrone in Patients with Very Active Relapsing-Remitting or Progressive Multiple Sclerosis

By  

European Neurology, Vol. 43, Iss. 3, 2000-04 ,pp. : 186-187

Karger

Access to resources Recommend Favorite

New Hypointense Lesions on MRI in Relapsing-Remitting Multiple Sclerosis Patients

By  

European Neurology, Vol. 43, Iss. 4, 2000-05 ,pp. : 194-200

Karger

Access to resources Recommend Favorite

Assessment of Driving Performance in Patients with Relapsing-Remitting Multiple Sclerosis by a Driving Simulator

By  

European Neurology, Vol. 50, Iss. 3, 2003-10 ,pp. : 160-164

Karger

Access to resources Recommend Favorite

Are Natalizumab and Fingolimod Analogous Second-Line Options for the Treatment of Relapsing-Remitting Multiple Sclerosis? A Clinical Practice Observational Study

By  

European Neurology, Vol. 72, Iss. 3-4, 2014-09 ,pp. : 173-180

Karger

Access to resources Recommend Favorite